Literature DB >> 17823263

The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.

Sandra M McLachlan1, Yuji Nagayama, Pavel N Pichurin, Yumiko Mizutori, Chun-Rong Chen, Alexander Misharin, Holly A Aliesky, Basil Rapoport.   

Abstract

Hyperthyroidism in Graves' disease is caused by thyroid-stimulating autoantibodies to the TSH receptor (TSHR), whereas hypothyroidism in Hashimoto's thyroiditis is associated with thyroid peroxidase and thyroglobulin autoantibodies. In some Graves' patients, thyroiditis becomes sufficiently extensive to cure the hyperthyroidism with resultant hypothyroidism. Factors determining the balance between these two diseases, the commonest organ-specific autoimmune diseases affecting humans, are unknown. Serendipitous findings in transgenic BALB/c mice, with the human TSHR A-subunit targeted to the thyroid, shed light on this relationship. Of three transgenic lines, two expressed high levels and one expressed low intrathyroidal A-subunit levels (Hi- and Lo-transgenics, respectively). Transgenics and wild-type littermates were depleted of T regulatory cells (Treg) using antibodies to CD25 (CD4(+) T cells) or CD122 (CD8(+) T cells) before TSHR-adenovirus immunization. Regardless of Treg depletion, high-expressor transgenics remained tolerant to A-subunit-adenovirus immunization (no TSHR antibodies and no hyperthyroidism). Tolerance was broken in low-transgenics, although TSHR antibody levels were lower than in wild-type littermates and no mice became hyperthyroid. Treg depletion before immunization did not significantly alter the TSHR antibody response. However, Treg depletion (particularly CD25) induced thyroid lymphocytic infiltrates in Lo-transgenics with transient or permanent hypothyroidism (low T(4), elevated TSH). Neither thyroid lymphocytic infiltration nor hypothyroidism developed in similarly treated wild-type littermates. Remarkably, lymphocytic infiltration was associated with intermolecular spreading of the TSHR antibody response to other self thyroid antigens, murine thyroid peroxidase and thyroglobulin. These data suggest a role for Treg in the natural progression of hyperthyroid Graves' disease to Hashimoto's thyroiditis and hypothyroidism in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823263     DOI: 10.1210/en.2007-1024

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  46 in total

Review 1.  Review and hypothesis: does Graves' disease develop in non-human great apes?

Authors:  Sandra M McLachlan; Kristine Alpi; Basil Rapoport
Journal:  Thyroid       Date:  2011-11-08       Impact factor: 6.568

2.  Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance for thyroid autoantigens.

Authors:  Alexander V Misharin; Yuji Nagayama; Holly A Aliesky; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2009-03-05       Impact factor: 4.736

Review 3.  Interferon alpha: The key trigger of type 1 diabetes.

Authors:  Angela Lombardi; Effie Tsomos; Sara S Hammerstad; Yaron Tomer
Journal:  J Autoimmun       Date:  2018-08-14       Impact factor: 7.094

4.  Nanoparticles Bearing TSH Receptor Protein and a Tolerogenic Molecule Do Not Induce Immune Tolerance but Exacerbate Thyroid Autoimmunity in hTSHR/NOD.H2h4 Mice.

Authors:  Sandra M McLachlan; Holly A Aliesky; Basil Rapoport
Journal:  J Immunol       Date:  2019-04-03       Impact factor: 5.422

5.  A unique mouse strain that develops spontaneous, iodine-accelerated, pathogenic antibodies to the human thyrotrophin receptor.

Authors:  Basil Rapoport; Holly A Aliesky; Bianca Banuelos; Chun-Rong Chen; Sandra M McLachlan
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

Review 6.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

7.  Role of the transgenic human thyrotropin receptor A-subunit in thyroiditis induced by A-subunit immunization and regulatory T cell depletion.

Authors:  Y Mizutori; Y Nagayama; D Flower; A Misharin; H A Aliesky; B Rapoport; S M McLachlan
Journal:  Clin Exp Immunol       Date:  2008-09-22       Impact factor: 4.330

Review 8.  A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocrine       Date:  2019-09-27       Impact factor: 3.633

Review 9.  Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Terry J Smith
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-10       Impact factor: 3.243

10.  The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon-alpha Therapy for Chronic Hepatitis C.

Authors:  Huy A Tran; Glenn E M Reeves
Journal:  Int J Endocrinol       Date:  2009-08-31       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.